Ramappa Chakrasali is an accomplished inventor based in Saint Paul, MN (US). He has made significant contributions to the field of fertility management and the treatment of polycystic kidney disease. With a total of 3 patents to his name, his work reflects a commitment to advancing medical science.

Latest Patents

One of his latest patents focuses on "Lonidamine analogues for fertility management." This invention outlines methods for administering compounds that can reduce fertility in subjects. The patent details various applications, including impairing Sertoli cell function in males and inhibiting spermatogenesis. It also addresses the potential for reversible fertility management through the cessation of compound administration.

Another significant patent is related to "Lonidamine analogues and treatment of polycystic kidney disease." This invention describes the use of lonidamine derivatives in treating, inhibiting, and preventing polycystic kidney disease (PKD). The methods include administering these derivatives in therapeutically effective amounts to inhibit specific biological pathways associated with PKD.

Career Highlights

Ramappa Chakrasali is affiliated with the University of Kansas, where he continues to engage in innovative research. His work has garnered attention for its potential impact on fertility and kidney health.

Collaborations

He has collaborated with notable colleagues, including Sudhakar Rao Jakkaraj and Joseph S Tash, to further his research endeavors.

Conclusion

Ramappa Chakrasali's contributions to medical science through his patents demonstrate his dedication to improving health outcomes. His innovative approaches in fertility management and kidney disease treatment highlight the importance of research in addressing critical health issues.